期刊文献+

IL-33/ST2对慢性阻塞性肺疾病肺动脉高压形成的影响 被引量:7

Effect of IL-33/ST2 on the Formation of Pulmonary Arterial Hypertension in Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 目的:研究慢性阻塞性肺疾病(COPD)患者血液及痰液IL-33/sST2水平与COPD肺动脉高压形成的关系。方法:将确诊COPD急性加重期的31例患者,依心脏彩超结果分为COPD伴肺动脉高压组(COPD-PAH)和COPD不伴肺动脉高压组(COPD-non PAH),取血液及痰液标本,ELISA法检测IL-33、sST2和IL-6,并进行多因素Logistic分析。25例健康志愿者为对照组(HC)。结果:1COPD-PAH组血清sST2水平显著高于COPD-non PAH组(P<0.05),两组血清IL-33、IL-6和痰液IL-33、sST2、IL-6水平无统计学差异。两组间多因素Logistic分析仅PaO2进入方程。2COPD-PAH组血清IL-33、sST2和IL-6水平显著高于HC组(P<0.05);COPD-non PAH组血清IL-33和IL-6水平显著高于HC组(P<0.05),但血清sST2水平与HC组无统计学差异。结论:IL-33、sST2、IL-6参与COPD的气道及全身炎症过程。sST2可能参与COPD-PAH形成的炎症机制。 Objective: To explore the correlation of IL-33/ST2 and the formation of pulmonary arterial hypertension (PAH) in chronic obstructive pulmonary disease (COPD). Methods: Thirty pa- tients diagnosed with AECOPD were recruited. The COPD patients were divided into COPD- PAH group (13 cases) and COPD-non PAH group (18 cases) according to the result of echocar- diography. The samples of blood and sputum were collected. The result of pulmonary function test, blood gas analysis and other clinical index of COPD patients were collected. Healthy volun- teers (25 cases) were enrolled as healthy control group (HC). Concentrations of IL-33, sST2, and IL-6 in serum and sputum samples were detected by ELISA. The multi-factorial logistic anal- ysis was done. Results: The serum level of sST2 in COPD-PAH group was higher than that in COPD-non PAH group (P〈0.05). No significant difference was found in serum IL-33, IL-6 or the sputum levels of sST2, IL-33 or IL-6 between the two groups. The multi-factorial logistic a- nalysis found that only the PaO2 was in the regression equation between these two groups. @COPD-PAH group had higher levels of serum IL-33, sST2 and IL-6(P〈0.05). As compared with HC, COPD-non PAH group had higher levels lar levels of serum sST2. Conclusion: IL-33, sST2 of serum IL-33 and IL-6(P〈0.05), but simi and IL-6 were involved in the chronic inflam matory process of COPD. The elevation of sST2 in serum was associated with the formation of PAH in COPD.
出处 《武汉大学学报(医学版)》 CAS 2016年第2期331-336,共6页 Medical Journal of Wuhan University
基金 湖北省卫生计生科研基金资助项目(编号:WJ2015MB099)
关键词 慢性阻塞性肺疾病 肺动脉高压 白细胞介素-33 ST2 白细胞介素-6 Chronic Obstructive Pulmonary Disease Pulmonary Arterial Hypertension Interleukin-33 ST2 Interleukin-6
  • 相关文献

参考文献16

  • 1Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for the Diagnosis,Management and Prevention of Chronic Obstructive Pulmonary Disease(updated 2014)[EB/OL].[2015-01-02].http://www.goldcopd.org/guidelines-global-strategy-for-dignosis-management.html.
  • 2Fang XC,Wang XD,Bai CX,et al.COPD in China:the burden and importance of proper management[J].Chest,2011,139(4):920-929.
  • 3Barbera JA,Peinado VI,Santos S.Pulmonary hypertension in chronic obstructive pulmonary disease[J].European Respiratory Journal,2003,21(5):892-905.
  • 4Fabbri LM,Luppi F,Beghe B,et al.Update in chronic obstructive pulmonary disease 2005[J].American Journal of Respiratory and Critical Care Medicine,2006,173(10):1 056-1 065.
  • 5Dinarello CA.An IL-1family member requires caspase-1processing and signals through the ST2receptor[J].Immunity,2005,23(5):461-462.
  • 6Miller AM,Liew FY.The IL-33/ST2pathway--A new therapeutic target in cardiovascular disease[J].Pharmacology&Therapeutics,2011,131(2):179-186.
  • 7Wu HX,Yang SF,Wu XJ,et al.Interleukin-33/ST2signaling promotes production of interleukin-6and interleukin-8in systemic inflammation in cigarette smokeinduced chronic obstructive pulmonary disease mice[J].Biochemical and Biophysical Research Communications,2014,450(1):110-116.
  • 8Joppa P,Petrasova D,Stancak B,et al.Systemic inflammation in patients with COPD and pulmonary hypertension[J].Chest,2006,130(2):326-333.
  • 9Shao D,Perros F,Caramori G,et al.Nuclear IL-33regulates soluble ST2receptor and IL-6expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension[J].Biochemical and Biophysical Research Communications,2014,451(1):8-14.
  • 10Barnes PJ.Immunology of asthma and chronic obstructive pulmonary disease[J].Nature Reviews Immunology,2008,8(3):183-192.

同被引文献87

  • 1S.Tresoldi,N.Flor,A.Luciani,etal.肿瘤病人胸部多层螺旋CT增强突发肺栓塞患病率的前瞻性评价及薄层重组的补充价值研究[J].国际医学放射学杂志,2016,39(1):85-86.
  • 2Amri Maleh V,Monadi M,Heidari B,et al.Efficiency and outcome of non-invasive versus invasive positive pressure ventilation therapy inrespiratory failure due to chronic obstructive pulmonary disease[J].Caspian J Intern Med,2016,7(2):99-104.
  • 3Pejkovska S,Kaeva BJ,Goseva Z,et al.Predictive factors for the effect of treatment by noninvasive ventilation in patients with respiratory failure as a result of acute exacerbation of the chronic obstructive pulmonary disease[J].Open Access Maced J Med Sci,2015,3(4):655-660.
  • 4Fan L,Zhao Q,Liu Y,et al.Semiquantitative cough strength score and associated outcomes in noninvasive positive pressure ventilation patients with acute exacerbation of chronic obstructive pulmonary disease[J].Respir Med,2014,108(12):1801-1807.
  • 5Ko BS,Ahn S,Lim KS,et al.Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure[J].Intern Emerg Med,2015,10(7):855-860.
  • 6Fiorino S,Bacchi-Reggiani L,Detotto E,et al.Efficacy of non-invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH<7.35:a feasibility pilot study[J].Intern Med J,2015,45(5):527-537.
  • 7Neame M,Aragon O,Fernandes RM,et al.Salbutamol or aminophylline for acute severe asthma:how to choose which one,when and why?[J].Arch Dis Child Educ Pract Ed,2015,100(4):215-222.
  • 8Mekov EV,Slavova YG,Genova MP,et al.Diabetes mellitus type 2in hospitalized COPD patients:impact on quality of life and lung function[J].Folia Med(Plovdiv),2016,58(1):36-41.
  • 9Asker S,Ozbay B,Ekin S,et al.Two-year survival of severe chronic obstructive pulmonary disease subjects requiring invasive mechanical ventilation and the factors affecting survival[J].J Pak Med Assoc,2016,66(5):498-503.
  • 10Barnes PJ.Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2016,138(1):16-27.

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部